Emerald Mutual Fund Advisers Trust’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio MRTX Stock Details MRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-27,224	Closed	-$4.66M	–	242
2021 Q1	$4.66M	Sell	27,224 -69,559	-72%	-$13.8M	0.15%	133
2020 Q4	$21.3M	Sell	96,783 -75,594	-44%	-$16.3M	0.74%	52
2020 Q3	$28.6M	Hold	172,377	–	–	1.27%	22
2020 Q2	$19.7M	Sell	172,377 -39,220	-19%	-$3.8M	0.93%	40
2020 Q1	$16.3M	Buy	211,597 +22,946	+12%	+$2.06M	1.02%	32
2019 Q4	$24.3M	Buy	188,651 +60,580	+47%	+$5.84M	0.99%	29
2019 Q3	$9.98M	Buy	+128,071	New	+$12M	0.44%	82

Other funds holding MRTX

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aviva Holdings New Providence, Bahamas $20.5M AUM 117.01% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's MRTX Position: Q2 2021 in Review

Emerald Mutual Fund Advisers Trust sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q2 2021, closing a stake of 27,224 shares — an estimated $4.66M sold.

Emerald Mutual Fund Advisers Trust first reported a position in MRTX in Q3 2019 and held it in 7 quarters. The position peaked at $28.6M in Q3 2020. 245 funds tracked by Wall St. Rank hold MRTX as of Q2 2021.

Emerald Mutual Fund Advisers Trust reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Emerald Mutual Fund Advisers Trust sold 27,224 Mirati Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $4.66M.
Emerald Mutual Fund Advisers Trust first reported a position in Mirati Therapeutics, Inc. Common Stock in Q3 2019 and held it in 7 quarters.
Emerald Mutual Fund Advisers Trust's Mirati Therapeutics, Inc. Common Stock position peaked at $28.6M in Q3 2020.
245 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2021, filed 29 Jul 2021.